본문 바로가기 주메뉴 바로가기
PIPELINE
home
PIPELINE

InnoCure is developing highly diifferentiated molecules for treatment of cancer and rare disease.

We have created a balanced portfolio of undruggable target.

ICT - 201

IndicationTNBC/NUT midline carcinoma

  • Discovery
  • IND Enabling
  • Phase l
  • Phase ll

ICT - 301

IndicationAdvanced solid tumor

  • Discovery
  • IND Enabling
  • Phase l
  • Phase ll

ICT - 401

IndicationPancreatic cancer

  • Discovery
  • IND Enabling
  • Phase l
  • Phase ll